Systemic immune‐checkpoint blockade with anti‐PD1 antibodies does not alter cerebral amyloid‐β burden in several amyloid transgenic mouse models
Martine Latta‐Mahieu(Sanofi (France)), Laurent Pradier(Sanofi (France)), Valérie Roudières(Sanofi (France)), Caroline Hersley(Eli Lilly (United States)), David Riddell(Eli Lilly (United States)), Philippe Goniot(Sanofi (France)), Liesbeth Mertens(Janssen (Belgium)), Pascal Barnéoud(Sanofi (France)), Peter H. Larsen(Lundbeck (Denmark)), Jirong Lu(Eli Lilly (United States)), Tyler McGathey(Eli Lilly (United States)), Gary J. Nabel(National Institutes of Health), Cindy Wintmolders(Janssen (Belgium)), Margaret M. Racke(Eli Lilly (United States)), Sofie Carmans, Nathalie Schussler(Sanofi (France)), Philìppe Bertrand(Sanofi (France)), Nicolas Moindrot(Sanofi (France)), Bradford Elmer(University of California, Davis), Astrid Bottelbergs(Janssen (Belgium)), Véronique Blanc(Sanofi (France)), Paul Ferrari(Sanofi (France)), Bart Roucourt, Alexis Bretteville(Inserm), Zhi‐Yong Yang(Wuhan University), Ling Liu(Children's Hospital of Fudan University), Michael O’Neill(Eli Lilly (United States)), Yaming Wang(Geological Museum of China), Andreas Ebneth(Evotec (Germany)), Véronique Blanchard(Sanofi (France)), Mati Lopez‐Grancha(Sanofi (France)), Emmanuel Brault(Sanofi (France))
Cited by 63
Related Papers
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
|Science|2010|1.8k
ApoE Promotes the Proteolytic Degradation of Aβ
|Neuron|2008|869
Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing
|Science|2011|820
Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine
|New England Journal of Medicine|2013|586
A cooperative interaction between NF‐kappa B and Sp1 is required for HIV‐1 enhancer activation.
|The EMBO Journal|1993|482